Dr. Ye Zhang 张烨
Chief Physician
Department of Neurosurgery, Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Individualized comprehensive treatment for gliomas, brain metastases, and primary CNS lymphoma. Surgery for complex skull base tumors (meningiomas, schwannomas) and spinal tumors. Minimally invasive treatment for pituitary and spinal tumors.
Dr. Zhang has worked in neurosurgery since 1999. The doctor leads one provincial major research project and two medical-engineering projects, and participates in national multi-center studies. Dr. Zhang has published multiple SCI articles and over ten papers in national core journals, and co-edited two monographs.
Professional roles
- Standing Committee Member and Secretary-General, Neuro-Oncology Professional Committee, China Anti-Cancer Association
- Member, International MDT Expert Group for Glioma
- Member, Brain Glioma Professional Committee, Chinese Medical Doctor Association
- Standing Committee Member, Neuro-Oncology Professional Committee, Liaoning Anti-Cancer Association
Name order: in Chinese the family name comes first (Zhang Ye). Papers usually list the name as Ye Zhang or Zhang Y.
Selected publications
32 papers on PubMed matched by name and affiliation; 8 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Immunol, 2024 (senior author): Recent advances in understanding the immune microenvironment in ovarian cancer. PubMed 38903506
- Front Immunol, 2023 (first author): The role of nanotherapy in head and neck squamous cell carcinoma by targeting tumor microenvironment. PubMed 37292204
- Oncol Rep, 2021 (first author): Circular RNA TADA2A promotes proliferation and migration via modulating of miR‑638/KIAA0101 signal in non‑small cell lung cancer. PubMed 34296306
- FASEB J, 2021 (senior author): Bufalin inhibits peritoneal dissemination of gastric cancer through endothelial nitric oxide synthase-mitogen-activated protein kinases signaling pathway. PubMed 33913201
- Front Oncol, 2021 (senior author): Pan-Cancer Analysis of NOS3 Identifies Its Expression and Clinical Relevance in Gastric Cancer. PubMed 33747912
- J Cell Physiol, 2019 (first author): Long noncoding RNA MT1JP inhibits proliferation, invasion, and migration while promoting apoptosis of glioma cells through the activation of PTEN/Akt signaling pathway. PubMed 31066040
- Exp Ther Med, 2019 (first author): Downregulation of miR-485-3p promotes glioblastoma cell proliferation and migration via targeting RNF135. PubMed 31258684
- Technol Cancer Res Treat, 2019 (first author): MicroRNA-374a Governs Aggressive Cell Behaviors of Glioma by Targeting Prokineticin 2. PubMed 30803356
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion